The funding brings Ganymed Robotics’ total to 35 million Euros, or approximately $38.2 million, according to a news release. The combined funds will help complete the company’s development of a total knee replacement robot, accelerate regulatory market activities and bolster the innovation product pipeline.
Ganymed Robotic in July raised 21 million Euros, or approximately $21.3 million. The company was founded in 2018.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
